Mylan News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

17.10.13	Mylan Appoints Jacek Glinka as President of Mylan's European Business (PR Newswire)
07.10.13	Mylan Schedules Third Quarter 2013 Financial Results Conference Call and Live Webcast (PR Newswire)
04.10.13	Morning Research: Johnson & Johnson, Mylan Inc., Brookdale Senior Living Inc., and Array BioPharma Inc. (PR Newswire)
30.09.13	Mylan Launches First Generic VFEND® for Oral Suspension (PR Newswire)
27.09.13	FTC Asks Mylan, Agila To Divest 11 Drugs To Approve Acquisition (RTTNews)
25.09.13	Mylan Confirms First-to-File Patent Challenge Relating to SAVELLA® (PR Newswire)
23.09.13	Teva Wins Azilect Patent Dispute Against Mylan - Quick Facts (RTTNews)
23.09.13	Mylan Supports GPhA's Filing Of Official Citizen Petition With FDA - Quick Facts (RTTNews)
23.09.13	Mylan Supports Generic Drug Industry's Call on FDA to Uphold Consistent, Proven International Standard for Biosimilar Naming (PR Newswire)
16.09.13	New Drug Applications, FDA Approvals, Approved Acquisitions, Divestitures and Licensing Agreements - Research Report on Merck, Allergan, Mylan, AstraZeneca, and GlaxoSmithKline (PR Newswire)
13.09.13	New Products, Philanthropic Initiative, Approved Acquisitions, and Pipeline Developments Boost Growth - Research Report on Mylan, UnitedHealth, GSK, Actavis, and Mallinckrodt (PR Newswire)
09.09.13	"Modern Family" Star Julie Bowen Narrates New Online Children's E-Book To Help Encourage School Communities to Talk About Anaphylaxis (PR Newswire)
05.09.13	Mylan to Speak at the Bank of America Merrill Lynch Global Healthcare Conference (PR Newswire)
05.09.13	Mylan to Speak at the Morgan Stanley Global Healthcare Unplugged Conference (PR Newswire)
04.09.13	Mylan Announces Completion of Transdermal Patch Facility Expansion Project in St. Albans, Vt. (PR Newswire)
03.09.13	Mylan Acquisition of Agila Receives Approval from India's Foreign Investment Promotion Board and Cabinet Committee on Economic Affairs (PR Newswire)
02.09.13	Approvals, Acquisitions, Note Redemptions and Invitations to Conferences - Research Report on Mylan, Warner Chilcott, Salix Pharmaceuticals, Mallinckrodt, and Akorn (PR Newswire)
29.08.13	Pre-Market Review: Johnson & Johnson, Mylan Inc., Brookdale Senior Living Inc., and Array BioPharma Inc. (PR Newswire)
22.08.13	Mylan Confirms Approval of sANDA for Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg (PR Newswire)
14.08.13	Mylan Kicks Off Second Year of Providing Free EpiPen® (epinephrine) Auto-Injectors to U.S. Schools (PR Newswire)
07.08.13	Collaborations, Global Platforms, and Strong Sales Drive Revenue Growth - Research Report on Baxter, Mylan, ImmunoGen, Emeritus, and Synta (PR Newswire)
01.08.13	Teva Q2 Profit Meets Estimates, While Mylan Profit Beats View; But Revenues Miss (RTTNews)
01.08.13	Mylan Q2 Profit Beats View; Backs FY13 Adj. EPS View - Quick Facts (RTTNews)
01.08.13	Mylan Reports a 13% Increase in Second Quarter 2013 Adjusted Diluted EPS to $0.68 (PR Newswire)
26.07.13	Court of Appeals Ruling on Teva Copaxone® Patent Allows Mylan May 2014 Launch (PR Newswire)
26.07.13	Mylan Confirms First-to-File Patent Challenge Regarding BANZEL - Quick Facts (RTTNews)
26.07.13	Mylan Confirms First-to-File Patent Challenge Relating to BANZEL® (PR Newswire)
25.07.13	Mylan Announces STALEVO Settlement Deal - Quick Facts (RTTNews)
25.07.13	Mylan Announces STALEVO® Settlement Agreement (PR Newswire)
24.07.13	Morning Research: Johnson & Johnson, Mylan, Array BioPharma, and Brookdale Senior Living (PR Newswire)
24.07.13	Mylan Reaches Tarceva Settlement Agreement With OSI, Pfizer And Genentech (RTTNews)
24.07.13	Mylan Announces TARCEVA® Settlement Agreement (PR Newswire)
23.07.13	Third Circuit Rules In Mylan's Favor On Paroxetine Hydrochloride ER Tablets (RTTNews)
23.07.13	Third Circuit Rules in Mylan's Favor Regarding Paroxetine Hydrochloride Extended-Release Tablets, Sending Mylan's Breach of Contract Claim Against GSK to Trial (PR Newswire)
18.07.13	Teva Found On Summary Judgment To Infringe Mylan Patent For Perforomist (RTTNews)
16.07.13	Court Rules In Favor Of Mylan Over Some Teva Copaxone Patents (RTTNews)
15.07.13	Mylan Confirms First-to-File Patent Challenge Regarding Vimpat - Quick Facts (RTTNews)
11.07.13	Mylan Confirms First-to-File Patent Challenge Relating To CANASA - Quick Facts (RTTNews)
08.07.13	Court Rules In Favor Of Mylan In Patent Infringement Litigation Against Sunovion (RTTNews)
20.05.08	Nebulized Formoterol Fumarate Has Comparable Pharmacokinetic and Pharmacodynamic Profile to Dry Powder Formulation (PR Newswire)
18.12.07	Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension (PR Newswire)
09.10.07	PARI Respiratory's LC PLUS & PRONEB Ultra Deliver Dey, L.P.'s New COPD Therapy; Perforomist Launched Yesterday (PR Newswire)
02.10.07	Mylan Announces Management of Specialty Business, Dey L.P. (PR Newswire)
01.06.07	Mylan Wins Omeprazole Patent Litigation (PR Newswire)
13.04.07	Mylan Announces Final FDA Approval for Glipizide and Metformin Hydrochloride Tablets (PR Newswire)
10.04.07	Mylan Increases Fiscal 2007 Adjusted Diluted EPS Guidance to $1.60 - $1.63 Excluding Any Contribution from the Recent Launch of Amlodipine Besylate (PR Newswire)
31.01.07	Mylan Laboratories Announces Strategic Global Reorganization to Maximize Growth Opportunities and Leverage Efficiencies Provided by New Global Platform (PR Newswire)
19.12.06	Mylan Announces Final FDA Approval for Finasteride Tablets USP, 5mg (PR Newswire)
20.07.06	Mylan Calls for End to Abusive Practices That Delay Access to Affordable Pharmaceuticals (PR Newswire)
09.05.06	Mylan Reports Fiscal 2006 Adjusted Diluted EPS at the Upper End of its Previously Issued Guidance of $1.00 (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

05.02.20		US-Pharmakonzern Biogen wehrt Patentklage von Mylan ab
05.09.18		Mylan übernimmt Rechte an Tobi-Inhalator von Novartis
09.08.17		Preisdruck bereitet Generikahersteller Mylan Probleme
13.03.17		Roche und Genentech einigen sich mit Mylan über Herceptin-Biosimilar
25.08.16		Mylan beugt sich dem politischen Druck
13.11.15		Mylan scheitert mit Einverleibung von Perrigo
14.09.15		Perrigo-Aktionäre können entscheiden
28.05.15		Mylan bringt Novartis und Pfizer ins Spiel

05.02.20

US-Pharmakonzern Biogen wehrt Patentklage von Mylan ab

05.09.18

Mylan übernimmt Rechte an Tobi-Inhalator von Novartis

09.08.17

Preisdruck bereitet Generikahersteller Mylan Probleme

13.03.17

Roche und Genentech einigen sich mit Mylan über Herceptin-Biosimilar

25.08.16

Mylan beugt sich dem politischen Druck

13.11.15

Mylan scheitert mit Einverleibung von Perrigo